ArticleF1000Research2026
Mapping Export Sustainability in Frozen Cephalopods: Destination Concentration and Revealed Comparative Advantage in China, Indonesia, India, Spain, Morocco, and Argentina (2020-2024).
Article in F1000Research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Frozen squid and cuttlefish (Harmonized System code 030743) form a commercially relevant segment of global cephalopod trade, with implications for cold-chain logistics, traceability and the economic resilience of exporting countries. Despite this relevance, comparable cross-country evidence on how export portfolios are structured and how relative specialization evolves remains limited. The study describes and compares destination diversification and revealed export positioning of frozen cephalopod exports for China, Indonesia, India, Spain, Morocco and Argentina between 2020 and 2024. Methods: A quantitative, non-experimental, retrospective longitudinal design was applied using secondary statistics from the United Nations International Trade Statistics Database (UN Comtrade). Destination diversification was measured through the Herfindahl-Hirschman Index (HHI), computed from the complete distribution of export shares across importing partners. Revealed specialization was assessed through the Revealed Symmetric Comparative Advantage (RSCA), obtained from the symmetric transformation of the Balassa index. The description was complemented with summary statistics (means, standard deviations, coefficients of variation and concentration ratios) and with exploratory non-parametric tests (Kruskal-Wallis, Friedman and Spearman correlations) that compare countries and years without inferring causal mechanisms; cleaning and harmonization followed documented routines to ensure replicability. Results: Cross-country heterogeneity was marked. China showed sustained deconcentration, with HHI declining from 1,134 to 704. India maintained a stable, moderately concentrated portfolio. Argentina moved from high concentration toward a more distributed structure, with partial reconcentration in 2024. Indonesia deepened its concentration, with HHI rising from 2,964 to 3,894, and Morocco remained highly concentrated throughout. Spain preserved high concentration despite redistribution among secondary markets. Between-country differences in HHI were large (Kruskal-Wallis H = 27.4, p < 0.001, ε Conclusions: Three descriptive export profiles were identified: diversified and stable; growth-oriented yet dependent; and specialized but destination-vulnerable. Supported by explicit summary statistics and exploratory tests, this typology offers a replicable baseline for sustainability discussions without inferring causal mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.